Amer Joseph

机构：Bayer (Germany)

发表论文 83 篇 · 总被引 7609 次 · h-index 29

代表论文

• A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease (2022 · Clinical Kidney Journal · 被引 103)
• Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes (2022 · Journal of Hypertension · 被引 95)
• A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetes (2022 · Kidney International · 被引 85)
• Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes (2023 · Clinical Journal of the American Society of Nephrology · 被引 55)
• Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis (2023 · European Heart Journal - Cardiovascular Pharmacotherapy · 被引 41)
• Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone (2023 · JAMA Cardiology · 被引 35)